| Gebruikt door |
als |
Naam |
Versie |
| 2.16.840.1.113883.2.4.3.11.60.3.10.0.6 |
Inclusie |
 zorgaanbieder entiteit (3.1.1)
|
2018‑06‑11 |
| 2.16.840.1.113883.2.4.3.11.60.3.10.0.7 |
 |
zorgaanbieder (3.1.1)
|
2018‑06‑11 |
| 2.16.840.1.113883.2.4.3.11.60.3.10.3.17 |
|
auteur
|
2018‑06‑11 |
| 2.16.840.1.113883.2.4.3.11.60.3.10.14 |
|
tabakgebruik (3.1)
|
2018‑06‑11 |
| 2.16.840.1.113883.2.4.3.11.60.110.10.24 |
|
 OncomdoSocialAnamnesis
|
2019‑01‑17 |
| 2.16.840.1.113883.2.4.3.11.60.3.10.18 |
|
alcoholgebruik (3.1)
|
2018‑06‑11 |
| 2.16.840.1.113883.2.4.3.11.60.3.10.22 |
|
drugsgebruik (3.2)
|
2018‑06‑11 |
| 2.16.840.1.113883.2.4.3.11.60.3.10.29 |
|
kleding
|
2018‑06‑11 |
| 2.16.840.1.113883.2.4.3.11.60.7.10.28 |
|
Lichaamsgewicht (3.1)
|
2017‑10‑25 |
| 2.16.840.1.113883.2.4.3.11.60.110.10.57 |
|
Oncozon LichamelijkOnderzoek sectie
|
2019‑03‑08 |
| 2.16.840.1.113883.2.4.3.11.60.110.10.104 |
|
Oncomdo CDA Generic Body
|
2020‑07‑17 |
| 2.16.840.1.113883.2.4.3.11.60.110.10.7 |
|
Oncomdo CDA generic component
|
2019‑01‑16 09:42:40 |
| 2.16.840.1.113883.2.4.3.11.60.110.10.296 |
|
Oncomdo CDA MDO Planning
|
2020‑10‑01 10:58:00 |
| 2.16.840.1.113883.2.4.3.11.60.110.10.5 |
|
Oncomdo CDA Generic Document
|
2019‑01‑16 09:39:27 |
| 2.16.840.1.113883.2.4.3.11.60.20.77.10.9234 |
|
 MP CDA (voorstel) Medicatieafspraak onderdelen 2 (907)
|
2018‑12‑04 14:08:53 |
| 2.16.840.1.113883.2.4.3.11.60.20.77.10.9233 |
|
MP CDA Medicatieafspraak inhoud (907)
|
2018‑12‑04 13:05:47 |
| 2.16.840.1.113883.2.4.3.11.60.20.77.10.9235 |
|
MP CDA Medicatieafspraak (907)
|
2018‑12‑04 14:33:21 |
| 2.16.840.1.113883.2.4.3.11.60.110.10.249 |
|
VoorgeschiedenisMedicatie
|
2020‑09‑08 |
| 2.16.840.1.113883.2.4.3.11.60.7.10.3.19 |
|
problem active (4.1)
|
2017‑10‑25 |
| 2.16.840.1.113883.2.4.3.11.60.110.10.288 |
|
Oncozon Conclusie en Advies Sectie
|
2020‑09‑18 |
| 2.16.840.1.113883.2.4.3.11.60.7.10.3.23 |
|
procedure activity
|
2017‑10‑25 |
| 2.16.840.1.113883.2.4.3.11.60.110.10.253 |
|
VerrichtingMetDosis
|
2020‑09‑15 |
| 2.16.840.1.113883.2.4.3.11.60.110.10.251 |
|
Oncozon Voorgeschiedenis Verrichtingen
|
2020‑09‑08 |
| 2.16.840.1.113883.2.4.3.11.60.7.10.3.24 |
|
procedure observation
|
2017‑10‑25 |
| 2.16.840.1.113883.2.4.3.11.60.7.10.45 |
|
problem concern act
|
2018‑02‑10 |
| 2.16.840.1.113883.2.4.3.11.60.110.10.250 |
|
Oncozon Anamnese
|
2017‑10‑24 |
| 2.16.840.1.113883.2.4.3.11.60.7.10.3.25 |
|
problem inactive
|
2018‑01‑20 |
| 2.16.840.1.113883.2.4.3.11.60.7.10.30 |
|
Lichaamslengte (3.1)
|
2017‑10‑25 |
| 2.16.840.1.113883.2.4.3.11.60.7.10.34 |
|
woonsituatie (3.1)
|
2018‑01‑20 |
| 2.16.840.1.113883.2.4.3.11.60.7.10.40 |
|
voedingsadvies (3.1)
|
2018‑01‑20 |
| 2.16.840.1.113883.2.4.3.11.60.3.10.3.29 |
Inclusie |
locatie
|
2018‑06‑11 |
OrganisatieLocatie
ity)